News & Views
News,
Telix Pharmaceuticals Limited is pleased to announce the establishment Telix Pharmaceuticals (Japan) Ltd and appointment of the first two members of the Japanese leadership…
Read more
Telix has today announced a collaboration with Memorial Sloan Kettering Cancer Center…
Read more
News,
Telix has today announced the appointment of Dr. Bernard Lambert as President and Chief Operating Officer (COO) of Telix’s US…
Read more
Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has successfully raised…
Read more
Telix Pharmaceuticals is pleased to announce that it has entered into a development and commercialisation partnership with Advanced Nuclear Medicine Ingredients SA…
Read more
Telix Pharmaceuticals Limited is pleased to announce the opening of its Initial Public Offering to raise A$50…
Read more
Telix is pleased to announce that it has entered into a technology licensing agreement and a research collaboration agreement with the University of…
Read more
Telix Pharmaceuticals is pleased to announce it has filed a $50 million Underwritten Initial Public…
Read more
Telix is pleased to announce the conclusion of collaboration and licensing agreement with CellSight Technologies, Inc. (CellSight) for the VisAcT immunoPET imaging technology…
Read more